Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
A new study finds that bariatric surgeries such as gastric bypass and sleeve gastrectomy are more effective in treating Type 2 diabetes than medication, a possible boon for device makers Allergan, Johnson & Johnson and GI Dynamics.
St. Jude Medical’s recalled Riata defibrillator leads have multiple issues that could lead to malfunction, a new study reports, but doctors are optimistic that the company’s Durata leads aren’t prone to the same defects.
Study results from the high-risk cohort A of the Partner trial finds that transcatheter aortic valve implantation stands up to surgical valve replacement at 2 years, but rates of paravalvular leakage increase with the less invasive TAVI procedure.